The epidemiology of varicella in school-aged Greek children before the implementation of universal vaccination

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 27, Issue 3, 2008, Pages 223-226

  Katsafadou, A ^a   Ferentinos, G ^b   Constantopoulos, A ^c   Papaevangelou, V ^c  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b Health Center Psahna   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ARTICLE; CHICKENPOX; DAY CARE; DEMOGRAPHY; DISEASE PREDISPOSITION; GREECE; HUMAN; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; SIBLING; VACCINATION;

AGE FACTORS; CHICKENPOX; CHILD; CHILD, PRESCHOOL; GREECE; HUMANS; QUESTIONNAIRES; STUDENTS;

EID: 41049084338     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-007-0418-x     Document Type: Article

References (15)

1. Arvin AM (2000) Varicella zoster virus. In: Behrman R, Kliegman R, Jensen H (eds) Nelson textbook of pediatrics, 15th edn. WB Saunders, Philadelphia, Pennsylvania, pp 1413-1418
2. Seward JF (2001) Update on varicella. Pediatr Infect Dis J 20:619-621
3. Coplan P, Black S, Rojas C, Shinefield H, Ray P, Lewis E, Guess H (2001) Incidence and hospitalization rates of varicella and herpes zoster before varicella vaccine introduction: a baseline assessment of the shifting epidemiology of varicella disease. Pediatr Infect Dis J 20:641-645
4. Centers for Disease Control and Prevention (1999) Prevention of varicella. Update recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 48(RR-6):1-5
5. Vinzio S, Lioure B, Goichot B (2006) Varicella in immunocompromised patients. Lancet 23(368):2208
6. Mullooly JP, Riedlinger K, Chun C, Weinmann S, Houston H (2005) Incidence of herpes zoster, 1997-2002. Epidemiol Infect 133:245-253
7. Weaver BA (2007) The burden of herpes zoster and postherpetic neuralgia in the United States. J Am Osteopath Assoc 107(Suppl 1):S2-S7
8. Pinot de Moira A, Nardone A; ESEN2 group (2005) Varicella zoster virus vaccination policies and surveillance strategies in Europe. Euro Surveill 10:43-45
9. Committee on Infectious Diseases (1995) Live attenuated varicella vaccine. Pediatrics 95:761-766
10. Nguyen HQ, Jumaan AO, Seward JF (2005) Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med 352:450-458
11. Vazeou TH et al (2000) Decrease in age of varicella infection in Greek children, 1989-1997. In: Proceedings of the 38th National Pediatric Conference, Greece
12. Rentier B, Gershon AA; European Working Group on Varicella (EuroVar) (2004) Consensus: varicella vaccination of healthy children-a challenge for Europe. Pediatr Infect Dis J 23:379-389
13. Nadone A et al (2007) The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 25(45):7866-7872
14. Meyer PA, Seward JF, Jumaan AO, Wharton M (2000) Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. J Infect Dis 182:383-390
15. Gabutti G, Penna C, Rossi M, Salmaso S, Rota MC, Bella A, Crovari P; Serological Study Group (2001) The seroepidemiology of varicella in Italy. Epidemiol Infect 126:433-440